NeueHealth, Inc. (NYSE:NEUE – Get Free Report) insider Jeffery Michael Craig sold 2,486 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $18,222.38. Following the completion of the transaction, the insider now owns 7,558 shares of the company’s stock, valued at approximately $55,400.14. This represents a 24.75 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
NeueHealth Price Performance
NeueHealth stock opened at $7.45 on Friday. The business has a 50 day simple moving average of $5.56 and a 200 day simple moving average of $5.40. The company has a market capitalization of $61.72 million, a PE ratio of -0.15 and a beta of 0.57. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $16.59.
Analyst Ratings Changes
Separately, Royal Bank of Canada dropped their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC acquired a new stake in shares of NeueHealth in the 2nd quarter valued at $312,000. Partners Group Holding AG bought a new position in NeueHealth during the 3rd quarter valued at about $463,000. Deer Management Co. LLC acquired a new position in NeueHealth in the second quarter valued at about $5,436,000. Finally, NEA Management Company LLC bought a new stake in NeueHealth during the second quarter worth about $14,834,000. 63.88% of the stock is currently owned by institutional investors and hedge funds.
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Articles
- Five stocks we like better than NeueHealth
- Comparing and Trading High PE Ratio Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- The Risks of Owning Bonds
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Consumer Staples Stocks, Explained
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.